Comparative Benefits of Primary Percutaneous Coronary Intervention Versus Onsite Fibrinolytic for Patients With ST-Segment-Elevation Myocardial Infarction: A Quasi-Experimental Study.
Zhou S, Xie S, You B, Xiang D, Fang W, Trisolini MG, Labresh KA, Smith SC Jr, Zheng ZJ, Jin Y, Liu F, Huo Y.
J Am Heart Assoc. 2025 Jul;14(13):e041995. doi: 10.1161/JAHA.125.041995. Epub 2025 Jun 23.
PMID:40551336
Multivessel vs. culprit-lesion only percutaneous coronary intervention in ST-elevation myocardial infarction.
Three-Year Outcomes With Fractional Flow Reserve-Guided or Angiography-Guided Multivessel Percutaneous Coronary Intervention for Myocardial Infarction.
Puymirat E, Cayla G, Simon T, Steg PG, Montalescot G, Durand-Zaleski I, Ngaleu Siaha F, Gallet R, Khalife K, Morelle JF, Motreff P, Lemesle G, Dillinger JG, Lhermusier T, Silvain J, Roule V, Labèque JN, Rangé G, Ducrocq G, Cottin Y, Blanchard D, Charles Nelson A, Djadi-Prat J, Chatellier G, Danchin N; FLOWER-MI Study Investigators.
Complete Revascularization by Percutaneous Coronary Intervention for Patients With ST-Segment-Elevation Myocardial Infarction and Multivessel Coronary Artery Disease: An Updated Meta-Analysis of Randomized Trials.
Ahmad Y, Howard JP, Arnold A, Prasad M, Seligman H, Cook CM, Warisawa T, Shun-Shun M, Ali Z, Parikh MA, Al-Lamee R, Sen S, Francis D, Moses JW, Leon MB, Stone GW, Karmpaliotis D.
J Am Heart Assoc. 2020 Jun 16;9(12):e015263. doi: 10.1161/JAHA.119.015263. Epub 2020 Jun 1.